Antibodies that cross react with the tumor antigen MUC1 switch a cellular immune response to a humoral one with implications for the immunotherapy of cancer (pages 315–320).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Apostolopoulos, V., Osinski, C. & McKenzie, I.F.C. MUC1 cross reactive galα(1,3)gal antibodies in humans switch immune responses from cellular to humoral. Nature Med. 4, 315–320 (1998).
Gendler, S., Taylor-Papadimitriou, J., Duhig, T., Rothbard, J. & Burchell, J. A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats. J. Biol. Chem. 263, 12820–12823 (1988).
Lloyd, K.O., Burchell, J., Kudryashov, V., Yin, B.W.T. & Taylor-Papadimitriou, J. Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. J. Biol. Chem. 271, 33325–33334 (1996).
Barnd, D.L., Lan, M.S., Metzgar, R.S. & Finn, O.J., fic, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. Proc. Natl. Acad. Sci. USA 86, 7159–7163(1989).
Gimmi, C.D. et al. Breast cancer-associated antigen, DF3/MUC1, induces apoptosis of activated human T cells. Nature Med. 2, 1367–1370 (1996).
Agrawal, B., Krantz, M.J., Reddish, M.A. & Longenecker, B.M. Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2. Nature Med. 4, 43–49 (1998).
Houghton, A.N. Cancer antigens: immune recognition of self and altered self. J. Exp. Med. 180, 1–4 (1994).
Colombo, M.P. & Forni, G. Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now? Immunol. Today 15, 48–51 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Houghton, A., Lloyd, K. Stuck in the MUC on the long and winding road. Nat Med 4, 270–271 (1998). https://doi.org/10.1038/nm0398-270
Issue date:
DOI: https://doi.org/10.1038/nm0398-270
This article is cited by
-
Vaccines for tumour prevention
Nature Reviews Cancer (2006)
-
Expression of Vicia villosa agglutinin (VVA)-binding glycoprotein in primary breast cancer cells in relation to lymphatic metastasis: is atypical MUC1 bearing Tn antigen a receptor of VVA?
Breast Cancer Research and Treatment (2006)
-
Lack of Polymorphism in MUC1 Tandem Repeats in Cancer Cells is Related to Breast Cancer Progression in Japanese Women
Breast Cancer Research and Treatment (2005)
-
Lack of Polymorphism in MUC1 Tandem Repeats in Cancer Cells is Related to Breast Cancer Progression in Japanese Women
Breast Cancer Research and Treatment (2005)
-
Immunotherapy for colorectal cancer
Current Oncology Reports (2001)
